Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
出版年份 2020 全文链接
标题
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
作者
关键词
-
出版物
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-07
DOI
10.1038/s41380-020-0740-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects
- (2019) Brendan D. Hare et al. Nature Communications
- Ketamine: A Paradigm Shift for Depression Research and Treatment
- (2019) John H. Krystal et al. NEURON
- MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients
- (2019) Daniella Dwir et al. MOLECULAR PSYCHIATRY
- SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A UNIQUE, NON-D2 RECEPTOR MECHANISM OF ACTION
- (2019) Nina Dedic et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test
- (2019) Paul J. Fitzgerald et al. PLoS One
- Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies
- (2019) Stephen J. Kaar et al. JOURNAL OF NEURAL TRANSMISSION
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- Deletion of dopamine D2receptors from parvalbumin interneurons in mouse causes schizophrenia-like phenotypes
- (2018) Eugenia Tomasella et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TrkB Regulates N-Methyl-D-Aspartate Receptor Signaling by Uncoupling and Recruiting the Brain-Specific Guanine Nucleotide Exchange Factor, RasGrf1
- (2018) Asghar Talebian et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18 F]-FDOPA PET study
- (2017) David R Bonsall et al. JOURNAL OF NEUROCHEMISTRY
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Beyond the Classic VTA: Extended Amygdala Projections to DA-Striatal Paths in the Primate
- (2017) Julie L Fudge et al. NEUROPSYCHOPHARMACOLOGY
- Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
- (2017) Juan L. Gomez et al. SCIENCE
- A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
- (2017) Sameer Jauhar et al. JAMA Psychiatry
- Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia
- (2016) Daniel W. Chung et al. AMERICAN JOURNAL OF PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
- (2016) Anthony A. Grace NATURE REVIEWS NEUROSCIENCE
- Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia
- (2016) John F Enwright et al. NEUROPSYCHOPHARMACOLOGY
- Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study
- (2016) Alexis C. Edwards et al. SCHIZOPHRENIA RESEARCH
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons
- (2015) Kareem S El Iskandrani et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Closing the translational gap between mutant mouse models and the clinical reality of psychotic illness
- (2015) Colm M. O’Tuathaigh et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The Role of Dopaminergic VTA Neurons in General Anesthesia
- (2015) Xuelong Zhou et al. PLoS One
- Restoring Mood Balance in Depression: Ketamine Reverses Deficit in Dopamine-Dependent Synaptic Plasticity
- (2014) Pauline Belujon et al. BIOLOGICAL PSYCHIATRY
- Downregulation of Neuregulin 1-ErbB4 Signaling in Parvalbumin Interneurons in the Rat Brain May Contribute to the Antidepressant Properties of Ketamine
- (2014) Nan Wang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- MAPK signaling correlates with the antidepressant effects of ketamine
- (2014) Gislaine Z. Réus et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Loss of Phenotype of Parvalbumin Interneurons in Rat Prefrontal Cortex Is Involved in Antidepressant- and Propsychotic-Like Behaviors Following Acute and Repeated Ketamine Administration
- (2014) ZhiQiang Zhou et al. MOLECULAR NEUROBIOLOGY
- Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
- (2014) D. Leo et al. NEUROPHARMACOLOGY
- Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
- (2014) Laura Pozzi et al. PLoS One
- Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
- (2014) E. S. Gideons et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fast-spiking, parvalbumin+ GABAergic interneurons: From cellular design to microcircuit function
- (2014) H. Hu et al. SCIENCE
- Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex
- (2013) Y. Usun et al. BEHAVIOURAL BRAIN RESEARCH
- Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
- (2013) Alice Egerton et al. BIOLOGICAL PSYCHIATRY
- Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
- (2013) Harvey A Whiteford et al. LANCET
- Diverging neural pathways assemble a behavioural state from separable features in anxiety
- (2013) Sung-Yon Kim et al. NATURE
- Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning
- (2013) Flavio Donato et al. NATURE
- Combinational effects of ketamine and amphetamine on behaviors and neurotransmitter systems of mice
- (2013) Chuan-Ching Lai et al. NEUROTOXICOLOGY
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
- (2013) Daehwan Kim et al. GENOME BIOLOGY
- Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
- (2013) Caroline A. Browne et al. Frontiers in Pharmacology
- Chronic Ketamine Reduces the Peak Frequency of Gamma Oscillations in Mouse Prefrontal Cortex Ex vivo
- (2013) James M. McNally et al. Frontiers in Psychiatry
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Topography of descending projections from anterior insular and medial prefrontal regions to the lateral habenula of the epithalamus in the rat
- (2012) Uhnoh Kim et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- In-vivo Measurement of LDOPA Uptake, Dopamine Reserve and Turnover in the Rat Brain Using [18F]FDOPA PET
- (2012) Matthew D Walker et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
- (2012) J M Stone et al. MOLECULAR PSYCHIATRY
- Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
- (2012) D. C. Javitt et al. SCHIZOPHRENIA BULLETIN
- NMDA Receptor and Schizophrenia: A Brief History
- (2012) J. T. Coyle SCHIZOPHRENIA BULLETIN
- Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
- (2011) Oliver D. Howes et al. AMERICAN JOURNAL OF PSYCHIATRY
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Dopamine D2 Receptor Occupancy and Clinical Effects
- (2011) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
- (2011) O Howes et al. MOLECULAR PSYCHIATRY
- How the 'slow' Ca2+ buffer parvalbumin affects transmitter release in nanodomain-coupling regimes
- (2011) Emmanuel Eggermann et al. NATURE NEUROSCIENCE
- Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
- (2011) Hiroyuki Koike et al. NEUROPHARMACOLOGY
- The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice
- (2011) Jesse S.O. Lindholm et al. NEUROPHARMACOLOGY
- In vivoandex vivoevidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia
- (2011) Sang-Young Kim et al. NMR IN BIOMEDICINE
- TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
- (2011) F. G. Revel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
- (2011) Daniel J. Lodge et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Trace amine-associated receptor 1 as a monoaminergic modulator in brain
- (2009) Zhihua Xie et al. BIOCHEMICAL PHARMACOLOGY
- A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia
- (2009) D. J. Lodge et al. JOURNAL OF NEUROSCIENCE
- The test–retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function
- (2009) Alice Egerton et al. NEUROIMAGE
- The Rostromedial Tegmental Nucleus (RMTg), a GABAergic Afferent to Midbrain Dopamine Neurons, Encodes Aversive Stimuli and Inhibits Motor Responses
- (2009) Thomas C. Jhou et al. NEURON
- Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs
- (2009) Silvia L. Cruz et al. PSYCHOPHARMACOLOGY
- Alterations in Somatostatin mRNA Expression in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia or Schizoaffective Disorder
- (2008) Harvey M. Morris et al. CEREBRAL CORTEX
- Prolonged Exposure to NMDAR Antagonist Suppresses Inhibitory Synaptic Transmission in Prefrontal Cortex
- (2008) Yuchun Zhang et al. JOURNAL OF NEUROPHYSIOLOGY
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
- (2008) John E. Lisman et al. TRENDS IN NEUROSCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started